Philippe Moulin

13.6k total citations
190 papers, 6.3k citations indexed

About

Philippe Moulin is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Philippe Moulin has authored 190 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Cardiology and Cardiovascular Medicine, 55 papers in Endocrinology, Diabetes and Metabolism and 54 papers in Surgery. Recurrent topics in Philippe Moulin's work include Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers), Lipid metabolism and disorders (36 papers) and Lipoproteins and Cardiovascular Health (31 papers). Philippe Moulin is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers), Lipid metabolism and disorders (36 papers) and Lipoproteins and Cardiovascular Health (31 papers). Philippe Moulin collaborates with scholars based in France, United States and United Kingdom. Philippe Moulin's co-authors include Fabrice Bonnet, François Berthézène, Jean‐Louis Terra, Alan R. Tall, Michael R. Skilton, Hubert Vidal, André Sérusclat, Eric Dusserre, Sophie Bernard and Agnès Sassolas and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Philippe Moulin

180 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Moulin France	43	2.2k	1.6k	1.6k	877	624	190	6.3k
Nader D. Nader United States	43	1.1k 0.5×	585 0.4×	1.3k 0.8×	1.5k 1.7×	511 0.8×	348	7.8k
Tommaso Gori Germany	48	4.4k 2.0×	566 0.3×	2.6k 1.6×	1.2k 1.3×	533 0.9×	322	10.5k
Lars Johansson Sweden	36	821 0.4×	819 0.5×	711 0.4×	691 0.8×	728 1.2×	125	5.1k
Hideki Ishii Japan	44	3.0k 1.3×	662 0.4×	2.4k 1.5×	1.1k 1.3×	447 0.7×	444	8.2k
Dimitrios Tousoulis Greece	35	2.4k 1.1×	572 0.3×	771 0.5×	558 0.6×	721 1.2×	274	4.6k
Gemma A. Figtree Australia	39	3.3k 1.5×	1.1k 0.7×	1.5k 1.0×	1.8k 2.1×	480 0.8×	282	7.6k
Sang‐Hak Lee South Korea	38	1.3k 0.6×	631 0.4×	1.4k 0.9×	720 0.8×	525 0.8×	238	4.4k
Krzysztof J. Filipiak‬ Poland	37	3.0k 1.4×	447 0.3×	1.3k 0.8×	958 1.1×	615 1.0×	502	6.0k
Martin Fiedler Germany	40	557 0.3×	458 0.3×	736 0.5×	1.3k 1.5×	561 0.9×	184	5.6k
Soo Wan Kim South Korea	41	968 0.4×	620 0.4×	699 0.4×	1.6k 1.8×	539 0.9×	423	6.5k

Countries citing papers authored by Philippe Moulin

Since Specialization

Citations

This map shows the geographic impact of Philippe Moulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Moulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Moulin more than expected).

Fields of papers citing papers by Philippe Moulin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Moulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Moulin. The network helps show where Philippe Moulin may publish in the future.

Co-authorship network of co-authors of Philippe Moulin

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Moulin. A scholar is included among the top collaborators of Philippe Moulin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Moulin. Philippe Moulin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown, Alan S., Philippe Moulin, Veronica J. Alexander, et al.. (2025). Brief communication: Strong concordance of the North American Familial Chylomicronemia Syndrome Score with a positive genetic diagnosis in patients from the Balance study. Journal of clinical lipidology. 19(5). 1451–1456. 1 indexed citations

Smati, Sarra, Matthieu Wargny, Jérôme Boursier, et al.. (2024). Prevalence of Liver Steatosis and Fibrosis in Adults With Primary Hypobetaliproteinemia: Results From the HYPOCHOL Study. Clinical Gastroenterology and Hepatology. 23(1). 166–168.e4.

Caussy, Cyrielle, Bruno Vergès, Valérie Hervieu, et al.. (2024). WED-194 Diagnostic performance of non-invasive tests and comparison of AGA and EASL algorithm for the screening of MASLD-related advanced fibrosis in diabetes and nutrition clinics. Journal of Hepatology. 80. S508–S508.

Bluteau, Olivier, Bertrand Cariou, Valérie Carreau, et al.. (2023). Additive Effect of APOE Rare Variants on the Phenotype of Familial Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 43(7). e270–e278. 3 indexed citations

Groisne, L., et al.. (2021). Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes. PLoS ONE. 16(5). e0251693–e0251693. 1 indexed citations

Cheillan, David, Mathilde Di Filippo, S. Lambert-Porcheron, et al.. (2020). Postprandial Triglyceride‐Rich Lipoproteins from Type 2 Diabetic Women Stimulate Platelet Activation Regardless of the Fat Source in the Meal. Molecular Nutrition & Food Research. 64(19). e2000694–e2000694. 6 indexed citations

Janin, Alexandre, Nicolas Chatron, Luc Dauchet, et al.. (2020). PCSK9 post-transcriptional regulation: Role of a 3′UTR microRNA-binding site variant in linkage disequilibrium with c.1420G. Atherosclerosis. 314. 63–70. 10 indexed citations

Cariou, Bertrand, Thomas Goronflot, Antoine Rimbert, et al.. (2020). Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study. Diabetes & Metabolism. 47(2). 101202–101202. 60 indexed citations

Cariou, Bertrand, Thomas Goronflot, Antoine Rimbert, et al.. (2020). Routine use of statins and increased mortality related to COVID-19 in inpatients with type 2 diabetes: Results from the CORONADO study.. Diabetes & Metabolism. 101202. 10 indexed citations

10.

Filippo, Mathilde Di, Sophie Collardeau‐Frachon, Alexandre Janin, et al.. (2019). Normal serum ApoB48 and red cells vitamin E concentrations after supplementation in a novel compound heterozygous case of abetalipoproteinemia. Atherosclerosis. 284. 75–82. 9 indexed citations

11.

Charrière, Sybil, Thomas Simonet, Véronique Bonnet, et al.. (2018). Single, short in‐del, and copy number variations detection in monogenic dyslipidemia using a next‐generation sequencing strategy. Clinical Genetics. 94(1). 132–140. 15 indexed citations

12.

Chen, Yinan, Françoise Hullin‐Matsuda, Carole Knibbe, et al.. (2018). In vitro oxidized HDL and HDL from type 2 diabetes patients have reduced ability to efflux oxysterols from THP-1 macrophages. Biochimie. 153. 232–237. 13 indexed citations

13.

Grenet, Guillaume, et al.. (2016). Protocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta‐analysis: GLUCOSE DINET protocol—Rational and design. Fundamental and Clinical Pharmacology. 31(3). 258–264. 4 indexed citations

14.

Cugnet‐Anceau, Christine, Julie‐Anne Nazare, Maria Biörklund, et al.. (2009). A controlled study of consumption of β-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. British Journal Of Nutrition. 103(3). 422–428. 59 indexed citations

15.

Moulin, Philippe & J. Christopher Beck. (2008). 46th Annual Allerton Conference on Communication, Control, and Computing : September 24-26, 2008. 1 indexed citations

16.

Zak, Zoulika, Thomas Gautier, Laure Dumont, et al.. (2004). Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats. Atherosclerosis. 178(2). 279–286. 9 indexed citations

17.

Dedecjus, Marek, David Masson, Thomas Gautier, et al.. (2003). Low cholesteryl ester transfer protein (CETP) concentration but normal CETP activity in serum from patients with short‐term hypothyroidism Lack of relationship to lipoprotein abnormalities. Clinical Endocrinology. 58(5). 581–588. 12 indexed citations

18.

Zak, Zoulika, Laurent Lagrost, Thomas Gautier, et al.. (2002). Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL. Journal of Lipid Research. 43(12). 2164–2171. 20 indexed citations

19.

Ponsin, Gabriel, Christophe Marçais, Laurence Duvillard, et al.. (2001). Ex VivoMeasurement of Lipoprotein Lipase-Dependent Very Low Density Lipoprotein (VLDL)-Triglyceride Hydrolysis in Human VLDL: An Alternative to the Postheparin Assay of Lipoprotein Lipase Activity?¹. The Journal of Clinical Endocrinology & Metabolism. 86(2). 797–803. 23 indexed citations

20.

Moulin, Philippe. (1995). La protéine de transfert du cholestérol estérifié (CETP). Sang thrombose vaisseaux. 7(7). 475–485. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact